CD8A and cancer: Anti-CD3 activated CD8+ TCM cells incubated with PD-L1N35A-expressing cancer cells showed the lowest degranulation and lysis in the presence of ICBs to PD-L1 or PD-1, significantly lower than PD-L1WT, indicating higher inhibition.